Pediatrix Medical Group, Inc.

Equities

MD

US58502B1061

Healthcare Facilities & Services

Real-time Estimate Cboe BZX Other stock markets 11:07:42 17/07/2024 pm IST			5-day change	1st Jan Change
7.775 ^USD	+2.03%		+13.40%	-17.20%

15/07	Truist Securities Cuts Price Target on Pediatrix Medical to $8 From $10, Maintains Hold Rating	MT
01/07	Pediatrix Medical Group, Inc.(NYSE:MD) dropped from Russell 2000 Value-Defensive Index	CI

Tranche Update on MEDNAX, Inc. (NYSE:MD)'s Equity Buyback Plan announced on July 30, 2013.

January 29, 2015 at 04:30 pm IST

From October 1, 2014 to December 31, 2014, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 2,678,563 shares, representing 2.69% for $178.56 million under the buyback announced on July 30, 2013.

Latest news about Pediatrix Medical Group, Inc.

Truist Securities Cuts Price Target on Pediatrix Medical to $8 From $10, Maintains Hold Rating	15/07	MT
Pediatrix Medical Group, Inc.(NYSE:MD) dropped from Russell 2000 Value-Defensive Index	01/07	CI
Pediatrix Medical Group, Inc.(NYSE:MD) dropped from Russell 2000 Defensive Index	01/07	CI
Pediatrix Medical Group, Inc. Eliminates Lee. A Wood as Executive Vice President, National and Market Operations, Effective as of July 5, 2024	18/06	CI
Deutsche Bank Upgrades Pediatrix Medical Group to Hold From Sell, $8 Price Target	07/06	MT
Transcript : Pediatrix Medical Group, Inc., Q1 2024 Earnings Call, May 07, 2024	07/05
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Posts Q1 Revenue $495.1M, vs. Street Est of $500.4M	07/05	MT
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Reports Q1 EPS $0.20, vs. Street Est of $0.19	07/05	MT
Pediatrix Medical Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05	CI
Pediatrix Medical Group, Inc. (NYSE:MD) acquired One maternal-fetal medicine practice for $9.7 million.	07/05	CI
Jefferies Cuts Price Target on Pediatrix Medical to $9 From $11, Maintains Hold Rating	06/03	MT
Deutsche Bank Trims Pediatrix Medical Group Price Target to $8 From $9, Maintains Sell Rating	21/02	MT
Mizuho Trims Price Target on Pediatrix Medical to $9 From $10, Maintains Neutral Rating	21/02	MT
Truist Securities Adjusts Price Target on Pediatrix Medical Group to $10 From $10.50, Keeps Hold Rating	21/02	MT
US Equity Markets Decline Tuesday Ahead of FOMC Meeting Minutes	21/02	MT
Pediatrix Medical Group Shares Fall After Q4 Adjusted Earnings, Revenue Decline	21/02	MT
Pediatrix Medical Group, Inc. Provides Earnings Guidance for the Year 2024	20/02	CI
Transcript : Pediatrix Medical Group, Inc., Q4 2023 Earnings Call, Feb 20, 2024	20/02
North American Morning Briefing : Earnings Back in -2-	20/02	DJ
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Posts Q4 Revenue $496.4M, vs. Street Est of $523.3M	20/02	MT
Earnings Flash (MD) PEDIATRIX MEDICAL GROUP Reports Q4 EPS $0.32, vs. Street Est of $0.32	20/02	MT
Pediatrix Medical Group, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	20/02	CI
UBS Initiates Coverage on Pediatrix Medical Group With Neutral Rating, $9.50 Price Target	30/11	MT
Deutsche Bank Cuts Pediatrix Medical Price Target to $9 From $14, Maintains Sell Rating	03/11	MT
Transcript : Pediatrix Medical Group, Inc., Q3 2023 Earnings Call, Nov 02, 2023	02/11

Chart Pediatrix Medical Group, Inc.

Duration

Period

More charts

Company Profile

Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Companyâs affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics. Its national network comprises over 2,620 affiliated physicians, including 1,330 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 580 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.

Sector

Healthcare Facilities & Services

Calendar

01/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Pediatrix Medical Group, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

7.62 USD

Average target price

8.214 USD

Spread / Average Target

+7.80%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
PEDIATRIX MEDICAL GROUP, INC.	-17.20%	631M
HCA HEALTHCARE, INC.	+19.71%	83.53B
CVS HEALTH CORPORATION	-22.74%	75.4B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+2.32%	26.73B
LABCORP HOLDINGS INC.	-4.18%	18.25B
FRESENIUS SE & CO. KGAA	+6.95%	18.12B
QUEST DIAGNOSTICS INCORPORATED	+8.47%	16.51B
NATERA, INC.	+78.42%	14.05B
TENET HEALTHCARE CORPORATION	+77.93%	13.03B
PURE HEALTH HOLDING	-27.89%	12.67B

Other Healthcare Facilities & Services